PA antes up for biodefense center vax facility; BMS taps Johnson Controls for facility management;

> Pennsylvania is making a $30-million contribution to the construction of an $830-million vaccine-producing biodefense center, to be built in Allegheny County. Article

> Bristol-Myers Squibb has selected Johnson Controls as its outsourcing partner to manage facilities in North America. Article

> Deacom, maker of enterprise resource planning software for the pharma and other vertical industries, has launched a social networking user group available via LinkedIn. Release

> Pharming Group and Sanofi Chimie have signed an agreement increasing production capacity for the drug substance Ruconest. Release

> The European Union is steering doctors toward prescribing Shire's Fabry disease drug Replagal rather than Genzyme's Fabrazyme due to the latter's ongoing manufacturing and supply challenges. Article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.